211 related articles for article (PubMed ID: 31727237)
1. Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells.
Di Virgilio F; Jiang LH; Roger S; Falzoni S; Sarti AC; Vultaggio-Poma V; Chiozzi P; Adinolfi E
Methods Enzymol; 2019; 629():115-150. PubMed ID: 31727237
[TBL] [Abstract][Full Text] [Related]
2. Effect of P2X7 receptor on tumorigenesis and its pharmacological properties.
Zhang WJ; Hu CG; Zhu ZM; Luo HL
Biomed Pharmacother; 2020 May; 125():109844. PubMed ID: 32004973
[TBL] [Abstract][Full Text] [Related]
3. Structure-based identification and characterisation of structurally novel human P2X7 receptor antagonists.
Caseley EA; Muench SP; Fishwick CW; Jiang LH
Biochem Pharmacol; 2016 Sep; 116():130-9. PubMed ID: 27481062
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel P2X7R antagonists by using structure-based virtual screening and cell-based assays.
Zhao Y; Chen X; Lyu S; Ding Z; Wu Y; Gao Y; Du J
Chem Biol Drug Des; 2021 Jul; 98(1):192-205. PubMed ID: 33993620
[TBL] [Abstract][Full Text] [Related]
5. P2X7 receptors: channels, pores and more.
Volonté C; Apolloni S; Skaper SD; Burnstock G
CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):705-21. PubMed ID: 22963440
[TBL] [Abstract][Full Text] [Related]
6. Structural and Functional Basis for Understanding the Biological Significance of P2X7 Receptor.
Martínez-Cuesta MÁ; Blanch-Ruiz MA; Ortega-Luna R; Sánchez-López A; Álvarez Á
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182829
[TBL] [Abstract][Full Text] [Related]
7. Microglia proliferation is controlled by P2X7 receptors in a Pannexin-1-independent manner during early embryonic spinal cord invasion.
Rigato C; Swinnen N; Buckinx R; Couillin I; Mangin JM; Rigo JM; Legendre P; Le Corronc H
J Neurosci; 2012 Aug; 32(34):11559-73. PubMed ID: 22915101
[TBL] [Abstract][Full Text] [Related]
8. A central role for P2X7 receptors in human microglia.
Janks L; Sharma CVR; Egan TM
J Neuroinflammation; 2018 Nov; 15(1):325. PubMed ID: 30463629
[TBL] [Abstract][Full Text] [Related]
9. P2X7 receptor inhibition by 2-amino-3-aryl-1,4-naphthoquinones.
de Luna Martins D; Borges AA; E Silva NADA; Faria JV; Hoelz LVB; de Souza HVCM; Bello ML; Boechat N; Ferreira VF; Faria RX
Bioorg Chem; 2020 Nov; 104():104278. PubMed ID: 33010623
[TBL] [Abstract][Full Text] [Related]
10. Unique residues in the ATP gated human P2X7 receptor define a novel allosteric binding pocket for the selective antagonist AZ10606120.
Allsopp RC; Dayl S; Schmid R; Evans RJ
Sci Rep; 2017 Apr; 7(1):725. PubMed ID: 28389651
[TBL] [Abstract][Full Text] [Related]
11. Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment.
Scarpellino G; Genova T; Munaron L
Recent Pat Anticancer Drug Discov; 2019; 14(1):32-38. PubMed ID: 30652649
[TBL] [Abstract][Full Text] [Related]
12. The phenothiazine-class antipsychotic drugs prochlorperazine and trifluoperazine are potent allosteric modulators of the human P2X7 receptor.
Hempel C; Nörenberg W; Sobottka H; Urban N; Nicke A; Fischer W; Schaefer M
Neuropharmacology; 2013 Dec; 75():365-79. PubMed ID: 23954492
[TBL] [Abstract][Full Text] [Related]
13. Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors.
Jelassi B; Anchelin M; Chamouton J; Cayuela ML; Clarysse L; Li J; Goré J; Jiang LH; Roger S
Carcinogenesis; 2013 Jul; 34(7):1487-96. PubMed ID: 23524196
[TBL] [Abstract][Full Text] [Related]
14. The cytokine IL-1beta transiently enhances P2X7 receptor expression and function in human astrocytes.
Narcisse L; Scemes E; Zhao Y; Lee SC; Brosnan CF
Glia; 2005 Jan; 49(2):245-58. PubMed ID: 15472991
[TBL] [Abstract][Full Text] [Related]
15. 8-Hydroxy-2-(1H-1,2,3-triazol-1-yl)-1,4-naphtoquinone derivatives inhibited P2X7 Receptor-Induced dye uptake into murine Macrophages.
Pacheco PAF; Galvão RMS; Faria AFM; Von Ranke NL; Rangel MS; Ribeiro TM; Bello ML; Rodrigues CR; Ferreira VF; da Rocha DR; Faria RX
Bioorg Med Chem; 2019 Apr; 27(8):1449-1455. PubMed ID: 30528164
[TBL] [Abstract][Full Text] [Related]
16. P2X7 receptor antagonism prevents IL-1β release from salivary epithelial cells and reduces inflammation in a mouse model of autoimmune exocrinopathy.
Khalafalla MG; Woods LT; Camden JM; Khan AA; Limesand KH; Petris MJ; Erb L; Weisman GA
J Biol Chem; 2017 Oct; 292(40):16626-16637. PubMed ID: 28798231
[TBL] [Abstract][Full Text] [Related]
17. P2X7 receptor antagonism inhibits tumour growth in human high-grade gliomas.
Kan LK; Seneviratne S; Drummond KJ; Williams DA; O'Brien TJ; Monif M
Purinergic Signal; 2020 Sep; 16(3):327-336. PubMed ID: 32583309
[TBL] [Abstract][Full Text] [Related]
18. The P2X7 purinergic receptor: a potential therapeutic target for lung cancer.
Li Q; Zhu X; Song W; Peng X; Zhao R
J Cancer Res Clin Oncol; 2020 Nov; 146(11):2731-2741. PubMed ID: 32892231
[TBL] [Abstract][Full Text] [Related]
19. The P2X7 receptor: A main player in inflammation.
Adinolfi E; Giuliani AL; De Marchi E; Pegoraro A; Orioli E; Di Virgilio F
Biochem Pharmacol; 2018 May; 151():234-244. PubMed ID: 29288626
[TBL] [Abstract][Full Text] [Related]
20. Activation of P2X7 receptor and NLRP3 inflammasome assembly in hippocampal glial cells mediates chronic stress-induced depressive-like behaviors.
Yue N; Huang H; Zhu X; Han Q; Wang Y; Li B; Liu Q; Wu G; Zhang Y; Yu J
J Neuroinflammation; 2017 May; 14(1):102. PubMed ID: 28486969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
